Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kodan is a brand of professional-grade alcoholic skin disinfectants and antiseptics widely used in clinical and surgical settings. The primary formulation, **Kodan Tinktur forte**, is an alcohol-based solution typically containing a combination of 2-propanol (isopropyl alcohol), 1-propanol, and sometimes biphenyl-2-ol (2-phenylphenol). It is indicated for preoperative skin disinfection, the prevention of surgical site infections, and the treatment of minor wounds. Its mechanism of action involves the rapid denaturation of microbial proteins and the disruption of cellular membranes, providing a broad antimicrobial spectrum that includes bactericidal (including MRSA), fungicidal, and virucidal (enveloped viruses like HBV, HIV, HCV) activities. Kodan is characterized by its rapid onset of action and sustained effect on the skin's microflora.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kodan.